Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Maxim Group Downgrades Pulse Biosciences to Hold

Maxim Group analyst Anthony Vendetti downgrades Pulse Biosciences (NASDAQ:PLSE) from Buy to Hold.
byBenzinga Newsdesk
September 21, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Maxim Group analyst Anthony Vendetti downgrades Pulse Biosciences (NASDAQ:PLSE) from Buy to Hold.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Israeli Psychedelics Biotech Shares Latest Advancements, Moves Forward With Addictions Treatment

By Lara Goldstein
December 19, 11:28 AM
Psychedelics company Clearmind Medicine Inc. (NASDAQ: CMND) aims to bring its proprietary compound, CMND-100, to clinical trials while developing additional proprietary psychedelic compounds for next-generation novel drug candidates, according to CEO Adi Zuloff-Shani.

CMND